As of Dec 12
| -0.3635 / -5.47%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.63, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +84.92% increase from the last price of 6.29.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.